Evidence map›Paper›PMID 41949217›Full record

ArticleActa obstetricia et gynecologica Scandinavica2026

Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population-based birth cohort study.

Johanna Lavi, Susanna Savukoski, Elisa Hurskainen, Meri-Maija Ollila, Laure Morin-Papunen, Maarit Niinimäki, Terhi T Piltonen

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Johanna LaviResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID 0009-0004-8258-4544
Susanna SavukoskiResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Elisa HurskainenResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Meri-Maija OllilaResearch Unit of Biomedicine and Internal Medicine, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID 0000-0002-6794-0369
Laure Morin-PapunenResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID 0000-0001-5987-7534
Maarit NiinimäkiResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID 0000-0003-0927-0472
Terhi T PiltonenResearch Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.ORCID 0000-0002-9921-7300

Funding

European Regional Development Fund (ERDF) 539/2010 A31592Ministry of Health and Social Affairs 160/97Ministry of Health and Social Affairs 190/97Ministry of Health and Social Affairs 23/251/97National Institute for Health and Welfare, Helsinki 54121Novo Nordisk Foundation (TTP)Oulun Yliopisto 24000692Oulun Yliopisto 65354Oulun Yliopistollinen Sairaala 24301140Oulun Yliopistollinen Sairaala 2/97Oulun Yliopistollinen Sairaala 8/97Oulu University UniOgsRegional Institute of Occupational Health, Oulu, Finland 50621Regional Institute of Occupational Health, Oulu, Finland 54231Roche Diagnostics International Ltd (TTP)Sigrid Jusélius Foundation (TTP), Research Council of Finland (TTP) 315921/2018Sigrid Jusélius Foundation (TTP), Research Council of Finland (TTP) 321763/2019Suomen Lääketieteen Säätiö
6 · The paper itself

Abstract

introductionWomen with polycystic ovary syndrome (PCOS) have been suggested to experience later menopause, yet population-based studies are lacking. The present study aimed to assess, in a population-based birth cohort, whether women with PCOS are more likely to experience late peri-/postmenopause or to have menopausal symptoms in their mid-40s than women without the syndrome. MATERIAL AND

methodsThe present study is a long-term, population-based prospective cohort study from the Northern Finland Birth Cohort 1966 (NFBC1966). The PCOS group (n = 380) was identified based on the Rotterdam criteria (oligomenorrhea, hyperandrogenism, or polycystic ovarian morphology according to anti-Müllerian hormone levels). Women who did not meet the Rotterdam criteria for PCOS were considered as controls (n = 1469). Late peri-/postmenopause was defined as at least 60 days of amenorrhea accompanied by elevated follicle-stimulating hormone levels (>25 IU/L) or the use of menopausal hormone therapy. In women who had undergone hysterectomy or were using progestins, menopausal status was defined as elevated follicle-stimulating hormone levels (>25 IU/L). Menopausal symptoms were self-reported via questionnaire during a follow-up visit at age 46.

resultsWomen with PCOS had a significantly lower likelihood of being late peri-/postmenopausal in their mid-40s compared with controls (PCOS: 3.1% vs. Controls: 18.4%; adjusted odds ratio 0.15, 95% confidence interval 0.07-0.32). To support this result, women with PCOS more often reported having regular menstrual cycles and had a lower risk of menopausal symptoms at age 46, even after adjusting for body mass index, education, and smoking status (adjusted odds ratio 0.68, 95% confidence interval 0.51-0.92). Hot flashes and sleep disturbances were less frequent among women with PCOS, but there were no differences in other menopause-related symptoms, such as vaginal dryness, affective symptoms, memory disturbances, or sexual dysfunction between the study groups.

conclusionsFrom the nonselective population data, it was shown that late peri-/postmenopausal status and symptoms were less frequent in women with PCOS at age 46, supporting the idea of prolonged ovarian function in affected women. This should be considered in patient counseling and future studies of fertility, contraception, and menopausal hormone therapy.

Indexed as

MenopausePolycystic Ovary SyndromeAdultCohort StudiesFemaleFinlandFollicle Stimulating HormoneHot FlashesHumansMiddle AgedPrevalenceProspective StudiesFollicle Stimulating Hormoneanti‐Müllerian hormonehot flashesmenopausal symptomsmenopausal transitionmenopauseperimenopausepolycystic ovary syndrome

Identifiers

PMID41949217
PMCPMC13125374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.